Amneal Pharmaceuticals, Inc. (AMRX) Balance Sheet
As of 2026-06-30 (10-Q), Amneal Pharmaceuticals, Inc. (AMRX) reported total assets of $3.8B and shareholders' equity of $33.0M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $127.6M. Long-term debt: $2.6B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AMRXAmneal Pharmaceuticals, Inc.Follow AMRX — free
—
Price chart with a free account
- Market cap
- 6.5B
- P/E TTM
- 41.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.07 | 0.21 | 0.15 | 0.34 | 0.25 | 0.03 | 0.09 | 0.11 | 0.28 | 0.13 | |
| Receivables | 0.35 | 0.48 | 0.60 | 0.64 | 0.66 | 0.74 | — | — | — | — | |
| Inventory | 0.28 | 0.46 | 0.38 | 0.49 | 0.49 | 0.53 | 0.58 | 0.61 | 0.61 | 0.68 | |
| Current assets | 0.77 | 1.29 | 1.21 | 1.55 | 1.52 | 1.41 | 1.38 | 1.59 | 1.91 | 1.95 | |
| Total assets | 1.34 | 4.35 | 3.67 | 4.01 | 3.94 | 3.80 | 3.47 | 3.50 | 3.68 | 3.78 | |
| Current liabilities | 0.30 | 0.55 | 0.55 | 0.68 | 0.68 | 0.75 | 0.85 | 1.13 | 0.88 | 0.88 | |
| Long-term debt | 1.36 | 2.63 | 2.61 | 2.74 | 2.68 | 2.59 | 2.39 | 2.16 | 2.57 | 2.56 | |
| Short-term debt | 0.09 | 0.02 | 0.02 | 0.04 | 0.03 | 0.03 | 0.03 | 0.22 | 0.01 | 0.01 | |
| Total liabilities | 0.00 | — | — | — | — | — | — | — | — | — | |
| Shareholders' equity | 0.00 | 0.50 | 0.23 | 0.30 | 0.36 | 0.30 | 0.02 | -0.11 | -0.07 | 0.03 |
USD billions · SEC XBRL
Amneal Pharmaceuticals, Inc. — questions
- How much cash does Amneal Pharmaceuticals, Inc. have?
- $127.6M in cash and cash equivalents as of 2026-06-30.
- How much debt does Amneal Pharmaceuticals, Inc. have?
- $2.6B of long-term debt and $6.0M due within a year as of 2026-06-30.
- What are Amneal Pharmaceuticals, Inc.'s total assets?
- $3.8B as of 2026-06-30.
- What is Amneal Pharmaceuticals, Inc.'s shareholders' equity?
- $33.0M as of 2026-06-30.
Every figure on this page comes from Amneal Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.